Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome

Jason R Schwartz, MD PhD, Jing Ma, PhD, Michael P Walsh, PhD, Xiaolong Chen, PhD, Tamara Lamprecht, BS, Jennifer Kamens, MD, Scott Newman, PhD, Jinghui Zhang, PhD, Tanja A. Gruber, MD PhD, Xiaotu Ma, Jeffery M. Klco, MD PhD

Blood (2019) 134 (Supplement_1): 1394.

https://doi.org/10.1182/blood-2019-128665

Published: 2019

Journal Articles

ASLAN003, a Novel and Potent Dihydroorotate Dehydrogenase (DHODH) Inhibitor, Induces Differentiation of Acute Myeloid Leukemia

Jianbiao Zhou, MD,PhD, Jessie Yiying Quah, B.S., Jing Yuan Chooi, BSc, Sabrina Hui-Min Toh, B.S., Yvonne Ng, B.S., Baohong Lin, B.S., Motomi Osato, MD, PhD, Qihui Seet, B.S., PhD, A.G. Lisa Ooi, B.S., PhD, Bertil Lindmark, MD PhD, Mark McHale, B.S., PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS

Blood (2018) 132 (Supplement 1): 4047.

https://doi.org/10.1182/blood-2018-99-114392

Published: 2018

Journal Articles

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Eileen Hu, BS, Jessica Waibl-Polania, BS, Frank Frissora, MS, Larry State Beaver, Kevan Zapolnik, BS, Bethany L Mundy-Bosse, PhD, Anjali Mishra, PhD, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, John C. Byrd, MD, Christopher C. Oakes, Michael Ostrowski, PhD, Natarajan Muthusamy, DVM, PhD

Blood (2018) 132 (Supplement 1): 2567.

https://doi.org/10.1182/blood-2018-99-115261

Published: 2018

Journal Articles

Alteration of CD47 Expression in Human and Murine Tumor Models Changes M1/M2 Phagocytosis Effect in Vitro and In Vivo

Huajun Yang, Zhongliang Li, Beibei Tang, Zegen Wang, Phillip Wang, Henry Li, PhD, Mohamad A. Cherry, MDMS, Frank Xing

Blood (2018) 132 (Supplement 1): 2395.

https://doi.org/10.1182/blood-2018-99-120268

Published: 2018

Journal Articles

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Jason R Schwartz, MD PhD, Michael P Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Raul C Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2018) 132 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2018-99-118995

Published: 2018

Journal Articles

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Edward Truelove, MBBS, BSc, MRCP, FRCPath, Frances Seymour, MRCP, BSc, MBBS, Janet Matthews, John G. Gribben

Blood (2018) 132 (Supplement 1): 2863.

https://doi.org/10.1182/blood-2018-99-119756

Published: 2018

Journal Articles

Natural Killer Receptor Ligand Expression By AML Blasts Determines Survival and Relapse Following Induction Chemotherapy

Sara Mastaglio, MD, Eric Wong, MD, Travis Perera, Ripley Jane, Piers Blombery, MBBS, Rachel Koldej, David Ritchie, MD PhD

Blood (2017) 130 (Supplement 1): 3948.

https://doi.org/10.1182/blood.V130.Suppl_1.3948.3948

Published: 2017

Journal Articles

Generation of Non-Hodgkin Lymphoma Patient-Derived Xenografts and in Depth Characterization of a Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma Model

Maarja-Liisa Nairismagi, PhD, Wan Lu Pang, BSc, DaChuan Huang, PhD, Jing Tan, PhD, Jing Quan Lim, PhD, Zhimei Li, MSc, Jeslin Ha, BSc, Yurike Laurensia, BSc, Giovani Claresta Wijaya, BSc, Cedric Chuan Young Ng, MSc, Erna Gondo Santoso, MSc, Bin Tean Teh, MD PhD, Soo-Yong Tan, MD PhD, Soon Thye Lim, MD, Choon Kiat Ong, PhD

Blood (2016) 128 (22): 4128.

https://doi.org/10.1182/blood.V128.22.4128.4128

Published: 2016

Journal Articles

Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets

David J Britton, PhD, Edmund Wilkes, BSc, PhD, Pedro Casado, PhD, Vinothini Rajeeve, PhD, Jude Fitzgibbon, John Gribben, Pedro R Cutillas, BSc, PhD

Blood (2016) 128 (22): 5265.

https://doi.org/10.1182/blood.V128.22.5265.5265

Published: 2016

Journal Articles

Tissue Sample Collection, Processing, Storage, Archiving and Usage in the Leukemia Tissue Bank: an M. D. Anderson Experience

Jairo Matthews, Sarah Gwen Pelletier, BS, Katie Gaw, Kavita Chauhan, Wilmer Flores, Manasi Chauhan, Giang Hoang, Elizabeth Graver, Jahn Laurel, Deanna Alexander, Sherry Pierce, BSN, BA, Steven M. Kornblau, MD

Blood (2016) 128 (22): 5168.

https://doi.org/10.1182/blood.V128.22.5168.5168

Published: 2016

Journal Articles

Leukaemic Secretion of Calcitriol: A Novel Mechanism of Hypercalcaemia in AML

Joshua Misha Lewis Casan, MB.BS(Hons), B.MDci (Hons), Sarah Ghotb, Sue Morgan, FRACP, FRCPA, MBBS, Stephen B Ting, MB BS, FRACP, FRCPA, PhD

Blood (2016) 128 (22): 5098.

https://doi.org/10.1182/blood.V128.22.5098.5098

Published: 2016

Journal Articles

The Genomic Landscape of Pediatric Myelodysplastic Syndromes

Jason R. Schwartz, MD PhD, Michael P. Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Shuoguo Wang, PhD, Gang Wu, PhD, John Easton, PhD, Raul C. Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2016) 128 (22): 956.

https://doi.org/10.1182/blood.V128.22.956.956

Published: 2016

Journal Articles

Cellular Iron Status Is Associated with Better Survival and Increased Chemotherapy Sensitivity in AML

Paul A. Seligman, MD, Shanshan Pei, PhD, Jeffrey R. Parrish, BS, Rhoda B. Schleicher, MS, Prakhar Singal, Craig T Jordan, PhD

Blood (2015) 126 (23): 4975.

https://doi.org/10.1182/blood.V126.23.4975.4975

Published: 2015

Journal Articles

Hepcidin and Atoh8 mRNA Expression Are Decreased in Murine Models of Hemochromatosis However Hepcidin Expression Is Unaffected By Atoh8 Knockout

Robert E Fleming, MD, Yihang Li, PhD, Ian Miller, BS, Princy Prasad, MS, Andrew McKie, PhD

Blood (2015) 126 (23): 947.

https://doi.org/10.1182/blood.V126.23.947.947

Published: 2015

Journal Articles

Next Generation Sequencing (NGS) Identifies an Association Between NPM1 Mutation and Leukemia Cutis

Marlise R. Luskin, MD, Campbell L. Stewart, MD, Jennifer JD Morrissette, PhD, David Lieberman, MS, CGC, David J. Margolis, MD, Alexander E. Perl, MD, Misha A. Rosenbach, MD

Blood (2014) 124 (21): 2341.

https://doi.org/10.1182/blood.V124.21.2341.2341

Published: 2014

Journal Articles

SIRT1 Expression Is Higher in Human Follicular Lymphoma and Correlates with Ki67 and Bcl-6 Overexpression

Raffaele Frazzi, PhD, Marco Tigano, PhD, Riccardo Valli, MD, Ione Tamagnini, PhD, Valentina Fragliasso, PhD, Francesco Merli, MD

Blood (2014) 124 (21): 1649.

https://doi.org/10.1182/blood.V124.21.1649.1649

Published: 2014

Journal Articles

The Genomic Landscape Of Primary Central Nervous System Lymphomas

Esteban Braggio, Ph.D., Brian Patrick O'Neill, MD, Scott Van Wier, Juhi Ojha, PhD, Jackline ayres-Silva, Riccardo Valdez, MD, Jan Egan, PhD, Ellen McPhail, MD, Maria Beatriz Lopes, David Schiff, MD, Raoul Tibes, MD, Keith Stewart, MBA, MB, CHB, Rafael Fonseca, M.D.

Blood (2013) 122 (21): 504.

https://doi.org/10.1182/blood.V122.21.504.504

Published: 2013

Journal Articles

Bi-Specific Killer Cell Engagers (BiKEs) Signaling Through CD16 and Targeting CD33 (CD16 × CD33), Triggers Natural Killer (NK) Cell Cytotoxic and Cytokine Production Against Refractory Acute Myeloid Leukemia (AML)

Andres Wiernik, MD, Bree Foley, PhD, Bin Zhang, Michael R. Verneris, MD, Erica Warlick, MD, Julie A. Ross, PhD, Louis M. Weiner, MD, Daniel J. Weisdorf, MD, Daniel A Vallera, PhD, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 256.

https://doi.org/10.1182/blood.V120.21.256.256

Published: 2012

Journal Articles

Organic Anion Transporting Polypeptide 1B (OATP1B) Transporters Modulate Hydroxyurea Pharmacokinetics

Aisha L. Walker, PhD, Cynthia S Lancaster, PhD, Russell E. Ware, MD, PhD, Alex Sparreboom, PhD

Blood (2012) 120 (21): 1008.

https://doi.org/10.1182/blood.V120.21.1008.1008

Published: 2012

Journal Articles

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

Blood (2012) 120 (21): 773.

https://doi.org/10.1182/blood.V120.21.773.773

Published: 2012

NARROW

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome

ASLAN003, a Novel and Potent Dihydroorotate Dehydrogenase (DHODH) Inhibitor, Induces Differentiation of Acute Myeloid Leukemia

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Alteration of CD47 Expression in Human and Murine Tumor Models Changes M1/M2 Phagocytosis Effect in Vitro and In Vivo

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Natural Killer Receptor Ligand Expression By AML Blasts Determines Survival and Relapse Following Induction Chemotherapy

Generation of Non-Hodgkin Lymphoma Patient-Derived Xenografts and in Depth Characterization of a Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma Model

Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets

Tissue Sample Collection, Processing, Storage, Archiving and Usage in the Leukemia Tissue Bank: an M. D. Anderson Experience

Leukaemic Secretion of Calcitriol: A Novel Mechanism of Hypercalcaemia in AML

The Genomic Landscape of Pediatric Myelodysplastic Syndromes

Cellular Iron Status Is Associated with Better Survival and Increased Chemotherapy Sensitivity in AML

Hepcidin and Atoh8 mRNA Expression Are Decreased in Murine Models of Hemochromatosis However Hepcidin Expression Is Unaffected By Atoh8 Knockout

Next Generation Sequencing (NGS) Identifies an Association Between NPM1 Mutation and Leukemia Cutis

SIRT1 Expression Is Higher in Human Follicular Lymphoma and Correlates with Ki67 and Bcl-6 Overexpression

The Genomic Landscape Of Primary Central Nervous System Lymphomas

Bi-Specific Killer Cell Engagers (BiKEs) Signaling Through CD16 and Targeting CD33 (CD16 × CD33), Triggers Natural Killer (NK) Cell Cytotoxic and Cytokine Production Against Refractory Acute Myeloid Leukemia (AML)

Organic Anion Transporting Polypeptide 1B (OATP1B) Transporters Modulate Hydroxyurea Pharmacokinetics

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only